Page 227 - Read Online
P. 227

dos Santos et al. J Cancer Metastasis Treat 2019;5:25  I  http://dx.doi.org/10.20517/2394-4722.2018.83                 Page 19 of 20

               78.   Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res
                   2002;62:1604-8.
               79.   Garg AD, Elsen S, Krysko DV, Vandenabeele P, de Witte P, et al. Resistance to anticancer vaccination effect is controlled by a cancer cell-
                   autonomous phenotype that disrupts immunogenic phagocytic removal. Oncotarget 2015;6:26841-60.
               80.   D’Cruz AK, Robinson MH, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer:
                   a multicenter study of 128 patients. Head Neck 2004;26:232-40.
               81.   Hopper C, Niziol C, Sidhu M. The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive
                   palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncol 2004;40:372-82.
               82.   Huang Z, Xu H, Meyers AD, Musani AI, Wang L, et al. Photodynamic therapy for treatment of solid tumors--potential and technical
                   challenges. Technol Cancer Res Treat 2008;7:309-20.
               83.   Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 2010;18:884-901.
               84.   Pogue BW, Elliott JT, Kanick SC, Davis SC, Samkoe KS, et al. Revisiting photodynamic therapy dosimetry: reductionist & surrogate
                   approaches to facilitate clinical success. Phys Med Biol 2016;61:R57-89.
               85.   Mallidi S, Anbil S, Bulin AL, Obaid G, Ichikawa M, et al. Beyond the barriers of light penetration: strategies, perspectives and possibilities
                   for photodynamic therapy. Theranostics 2016;6:2458-87.
               86.   Schweitzer C, Schmidt R. Physical mechanisms of generation and deactivation of singlet oxygen. Chem Rev 2003;103:1685-757.
               87.   Lovell JF, Liu TWB, Chen J, Zheng G. Activatable photosensitizers for imaging and therapy. Chem Rev 2010;110:2839-57.
               88.   Dang J, He H, Chen D, Yin L. Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT). Biomater Sci 2017;5:1500-11.
               89.   Sitnik TM, Hampton JA, Henderson BW. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of
                   fluence rate. Br J Cancer 1998;77:1386-94.
               90.   Penjweini R, Kim MM, Finlay JC, Zhu TC. Investigating the impact of oxygen concentration and blood flow variation on photodynamic
                   therapy. Proc SPIE Int Soc Opt Eng 2016;9694:1-13.
               91.   Turan IS, Yildiz D, Turksoy A, Gunaydin G, Akkaya EU. A bifunctional photosensitizer for enhanced fractional photodynamic therapy:
                   singlet oxygen generation in the presence and absence of light. Angew Chem Int Ed Engl 2016;55:2875-8.
               92.   Protti S, Albini A, Viswanathan R, Greer A. Targeting photochemical scalpels or lancets in the photodynamic therapy field-the
                   Photochemist’s role. Photochem Photobiol 2017;93:1139-53.
               93.   Stringasci MD, Fortunato TC, Moriyama LT, Filho JDV, Bagnato VS, et al. Interstitial PDT using diffuser fiber-investigation in phantom
                   and in vivo models. Lasers Med Sci 2017;32:1009-16.
               94.   Kessel D, Reiners JJ. Enhanced efficacy of photodynamic therapy via a sequential targeting protocol. Photochem Photobiol
                   2014;90:889-95.
               95.   Cincotta L, Szeto D, Lampros E, Hasan T, Cincotta AH. Benzophenothiazine and benzoporphyrin derivative combination phototherapy
                   effectively eradicates large murine sarcomas. Photochem Photobiol 1996;63:229-37.
               96.   Ang JM, Riaz I Bin, Kamal MU, Paragh G, Zeitouni NC. Photodynamic therapy and pain: a systematic review. Photodiagnosis Photodyn
                   Ther 2017;19:308-44.
               97.   Tardivo JP, Adami F, Correa JA, Pinhal MAS, Baptista MS. A clinical trial testing the efficacy of PDT in preventing amputation in diabetic
                   patients. Photodiagnosis Photodyn Ther 2014;11:342-50.
               98.   Zhu S, Zhang Q, Sun X, Zeh HJ, Lotze MT, et al. HSPA5 regulates ferroptotic cell death in cancer cells. Cancer Res 2017;77:2064-77.
               99.   Eckhardt BL, Francis PA, Parker BS, Anderson RL. Strategies for the discovery and development of therapies for metastatic breast cancer.
                   Nat Rev Drug Discov 2012;11:479-97.
               100.  Khan SA, Dougherty TJ, Mang TS. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer.
                   Eur J Cancer 1993;29A:1686-90.
               101.  Montazerabadi AR, Sazgarnia A, Bahreyni-toosi MH, Ahmadi A, Aledavood A. The effects of combined treatment with ionizing radiation
                   and indocyanine green-mediated photodynamic therapy on breast cancer cells. J Photochem Photobiol B Biol 2012;109:42-9.
               102.  Lo VCK, Akens MK, Moore S, Yee AJM, Wilson BC, et al. Beyond radiation therapy: photodynamic therapy maintains structural integrity
                   of irradiated healthy and metastatically involved vertebrae in a pre-clinical in vivo model. Breast Cancer Res Treat 2012;135:391-401.
               103.  Lo VCK, Akens MK, Wise-Milestone L, Yee AJM, Wilson BC, et al. The benefits of photodynamic therapy on vertebral bone are
                   maintained and enhanced by combination treatment with bisphosphonates and radiation therapy. J Orthop Res 2013;31:1398-405.
               104.  Crescenzi E, Varriale L, Iovino M, Chiaviello A, Veneziani BM, et al. Photodynamic therapy with indocyanine green complements and
                   enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol Cancer Ther 2004;3:537-44.
               105.  Zimmermann A, Walt H, Haller U, Baas P, Klein SD. Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines
                   in vitro and in a patient. Cancer Chemother Pharmacol 2003;51:147-54.
               106.  Aniogo EC, George BPA, Abrahamse H. In vitro combined effect of Doxorubicin and sulfonated zinc Phthalocyanine-mediated photodynamic
                   therapy on MCF-7 breast cancer cells. Tumour Biol 2017;39:1010428317727278.
               107.  Tong Z, Miao P, Liu T, Jia Y, Liu X. Enhanced antitumor effects of BPD-MA-mediated photodynamic therapy combined with adriamycin
                   on breast cancer in mice. Acta Pharmacol Sin 2012;33:1319-24.
               108.  Tsuchihashi T, Mori K, Ueyama K, Yoneya S. Five-year results of photodynamic therapy with verteporfin for Japanese patients with
                   neovascular age-related macular degeneration. Clin Ophthalmol 2013;7:615-20.
               109.  Pece A, Milani P, Isola V, Pierro L. A long-term study of photodynamic therapy with verteporfin for choroidal neovascularization at the edge
                   of chorioretinal atrophy in pathologic myopia. Ophthalmologica 2011;225:161-8.
               110.  Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
               111.  Allison RR, Sibata CH. Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagnosis Photodyn Ther 2010;7:61-75.
               112.  Breskey JD, Lacey SE, Vesper BJ, Paradise WA, Radosevich JA, et al. Photodynamic therapy: occupational hazards and preventative
                   recommendations for clinical administration by healthcare providers. Photomed Laser Surg 2013;31:398-407.
   222   223   224   225   226   227   228   229   230   231   232